Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Henryk Barthel(University Hospital Leipzig), Hermann‐Josef Gertz(Leipzig University), S. Dresel(Helios Hospital Berlin-Buch), Oliver Peters(Charité - Universitätsmedizin Berlin), Peter Bartenstein(Ludwig-Maximilians-Universität München), Katharina Büerger(Ludwig-Maximilians-Universität München), Florian Hiemeyer(Bayer (Germany)), Sabine Wittemer‐Rump(Bayer (Germany)), John Seibyl(Elucid Bioimaging), Cornelia Reininger(Bayer (Germany)), Osama Sabri(Leipzig University)
The Lancet Neurology
April 11, 2011
Cited by 584

Abstract


Related Papers

No related papers found

Powered by citation graph analysis